Background Women who carry a mutation for Lynch syndrome face complex decisions regarding strategies for managing their increased cancer risks. At present, there is limited understanding of the factors influencing women’s prophylactic surgery decisions. Methods As part of an exploratory pilot project, semi-structured interviews were conducted with 10 women who were Lynch syndrome mutation carriers and had made prophylactic surgery decisions. Nine of 10 women had chosen to undergo prophylactic hysterectomy and/or oophorectomy as a means of managing their increased gynecological cancer risks. Results Study findings revealed that surgery decisions were influenced by multiple factors, including demographic variables such as age and par...
Many, women who have, or are at risk for, BRCA, 1/2 mutations or breast cancer decline prophylactic ...
Women found to carry mutations in the BRCA1 or BRCA2 genes have up to an 88% lifetime risk of breast...
With technological advances in testing for gene mutations, a new population of BRCA1/2 women is beco...
To prevent endometrial carcinoma in Lynch syndrome (LS), regular gynecological surveillance visits a...
li disposing carriers to a high risk of early-onset colorectal cancer [1-5]. LS is caused by mutatio...
Hereditary women’s syndromes due to inherited mutations result in an elevated risk of developing gyn...
Purpose: To survey risk-reducing hysterectomy and bilateral salpingo-oophorectomy (BSO) practice and...
PURPOSE: To survey risk-reducing hysterectomy and bilateral salpingo-oophorectomy (BSO) practice and...
Women who have a breast cancer genetic mutation (BRCA) are at a significantly increased risk for the...
Lynch syndrome (LS) is caused by a germline mutations in DNA mismatch repair genes and is a dominant...
Purpose: To survey risk-reducing hysterectomy and bilateral salpingo-oophorectomy (BSO) practice and...
Women with a family history of breast or ovarian cancers may be eligible for genetic testing to see ...
Purpose: To survey risk-reducing hysterectomy and bilateral salpingo-oophorectomy (BSO) practice and...
PURPOSE: To survey risk-reducing hysterectomy and bilateral salpingo-oophorectomy (BSO) practice and...
Background There is limited research on why some individuals who have undergone predictive gen...
Many, women who have, or are at risk for, BRCA, 1/2 mutations or breast cancer decline prophylactic ...
Women found to carry mutations in the BRCA1 or BRCA2 genes have up to an 88% lifetime risk of breast...
With technological advances in testing for gene mutations, a new population of BRCA1/2 women is beco...
To prevent endometrial carcinoma in Lynch syndrome (LS), regular gynecological surveillance visits a...
li disposing carriers to a high risk of early-onset colorectal cancer [1-5]. LS is caused by mutatio...
Hereditary women’s syndromes due to inherited mutations result in an elevated risk of developing gyn...
Purpose: To survey risk-reducing hysterectomy and bilateral salpingo-oophorectomy (BSO) practice and...
PURPOSE: To survey risk-reducing hysterectomy and bilateral salpingo-oophorectomy (BSO) practice and...
Women who have a breast cancer genetic mutation (BRCA) are at a significantly increased risk for the...
Lynch syndrome (LS) is caused by a germline mutations in DNA mismatch repair genes and is a dominant...
Purpose: To survey risk-reducing hysterectomy and bilateral salpingo-oophorectomy (BSO) practice and...
Women with a family history of breast or ovarian cancers may be eligible for genetic testing to see ...
Purpose: To survey risk-reducing hysterectomy and bilateral salpingo-oophorectomy (BSO) practice and...
PURPOSE: To survey risk-reducing hysterectomy and bilateral salpingo-oophorectomy (BSO) practice and...
Background There is limited research on why some individuals who have undergone predictive gen...
Many, women who have, or are at risk for, BRCA, 1/2 mutations or breast cancer decline prophylactic ...
Women found to carry mutations in the BRCA1 or BRCA2 genes have up to an 88% lifetime risk of breast...
With technological advances in testing for gene mutations, a new population of BRCA1/2 women is beco...